ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,601
Diagnostic referrals
1,060
Outstanding pathways
335

Screening pathway

  1. Screening5,601Encounters
  2. Positive finding1,983Documented findings
  3. Referral1,060Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 50.

Participant insight

Expanded synthetic participant 0166 · EXP-0166Synthetic · Site D

Full participant history through 2027-10-08, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-11
  4. · Diagnostic referral · EXP-0166-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Reached
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · High-grade lesion
  11. · Follow-up disposition · Resolved · EXP-0166-T-R
  12. · Treatment · Synthetic precancer treatment
  13. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-05-18
  14. · Screening · HPV DNA · Repeat · Prior VIA positive
  15. · Screening result · HPV DNA · HPV not detected · Adequate
  16. · Surveillance · HPV DNA · Surveillance · After treatment
  17. · Surveillance result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0481 · Expanded synthetic participant 0481Site C — Rural Outreach Programme
EXP-0482 · Expanded synthetic participant 0482Site A — Urban Referral Hub
EXP-0483 · Expanded synthetic participant 0483Site E — Resource-Constrained Navigation Programme
EXP-0484 · Expanded synthetic participant 0484Site A — Urban Referral Hub
EXP-0485 · Expanded synthetic participant 0485Site A — Urban Referral Hub
EXP-0487 · Expanded synthetic participant 0487Site E — Resource-Constrained Navigation Programme
EXP-0488 · Expanded synthetic participant 0488Site C — Rural Outreach Programme
EXP-0489 · Expanded synthetic participant 0489Site A — Urban Referral Hub
EXP-0490 · Expanded synthetic participant 0490Site B — Peri-Urban Access Programme
EXP-0491 · Expanded synthetic participant 0491Site D — Community Engagement Programme
EXP-0492 · Expanded synthetic participant 0492Site E — Resource-Constrained Navigation Programme
EXP-0493 · Expanded synthetic participant 0493Site A — Urban Referral Hub
EXP-0494 · Expanded synthetic participant 0494Site D — Community Engagement Programme
EXP-0495 · Expanded synthetic participant 0495Site D — Community Engagement Programme
EXP-0496 · Expanded synthetic participant 0496Site B — Peri-Urban Access Programme
EXP-0497 · Expanded synthetic participant 0497Site D — Community Engagement Programme
EXP-0498 · Expanded synthetic participant 0498Site E — Resource-Constrained Navigation Programme
EXP-0499 · Expanded synthetic participant 0499Site A — Urban Referral Hub
EXP-0500 · Expanded synthetic participant 0500Site A — Urban Referral Hub
EXP-0501 · Expanded synthetic participant 0501Site A — Urban Referral Hub
EXP-0502 · Expanded synthetic participant 0502Site D — Community Engagement Programme
EXP-0503 · Expanded synthetic participant 0503Site C — Rural Outreach Programme
EXP-0504 · Expanded synthetic participant 0504Site D — Community Engagement Programme
EXP-0505 · Expanded synthetic participant 0505Site A — Urban Referral Hub
EXP-0508 · Expanded synthetic participant 0508Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1970
HPV DNA
2904
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.